These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4992593)

  • 41. The action of glucosulphone [N,N'-di (glucose sodium sulphonate) of 4,4'-diaminodiphenyl sulphone] on pancreatic kallikrein.
    Abitbol H; Piulats E; Roselló S
    Br J Pharmacol; 1969 Sep; 37(1):168-71. PubMed ID: 4390480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Studies on the localization of changes in vascular permeability].
    Waldvogel G; Frimmer M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(4):321-33. PubMed ID: 4174079
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacological data on phyllokinin (bradykinyl-isoleucyl-tyrosine o-sulphate) and bradykinyl-isoleucyl-tyrosine.
    Anastasi A; Bertaccini G; Erspamer V
    Br J Pharmacol Chemother; 1966 Sep; 27(3):479-85. PubMed ID: 5970899
    [No Abstract]   [Full Text] [Related]  

  • 44. A comparative study of kinin, kallidin, and bradykinin.
    HOLDSTOCK DJ; MATHIAS AP; SCHACHTER M
    Br J Pharmacol Chemother; 1957 Jun; 12(2):149-58. PubMed ID: 13446366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Determination method for plasma kinin and related enzymes and their role in various disease states].
    Katori M
    Arerugi; 1969 Jun; 18(6):505-17. PubMed ID: 4898588
    [No Abstract]   [Full Text] [Related]  

  • 46. Measurement of rate of extravasation of plasma protein in inflammatory responses in guinea-pig skin using a continuous recording method.
    Williams TJ; Morley J
    Br J Exp Pathol; 1974 Feb; 55(1):1-12. PubMed ID: 4835793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Guinea pig plasma kallikrein as a vascular permeability enhancement factor. Its dependence on kinin generation and regulation mechanisms in vivo.
    Imamura T; Yamamoto T; Kambara T
    Am J Pathol; 1984 Apr; 115(1):92-101. PubMed ID: 6424481
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antinociceptive action of bradykinin and related kinins of larger molecular weights by the intraventricular route.
    Ribeiro SA; Silva MR
    Br J Pharmacol; 1973 Mar; 47(3):517-28. PubMed ID: 4730829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [New antibiotic, Josamycin. VII. Pharmacological study].
    Kuriaki K; Nozaki Y; Ida H; Kagami S; Odani Y
    Jpn J Antibiot; 1969 Jun; 22(3):232-41. PubMed ID: 4390288
    [No Abstract]   [Full Text] [Related]  

  • 50. [Plasminogen activator: human granulocyte "kininogenase"; inhibition by an acid-stable inhibitor from blood plasma].
    Ogloblina OG; Platonova LV; Paskhina TS
    Dokl Akad Nauk SSSR; 1982; 265(4):982-5. PubMed ID: 6813087
    [No Abstract]   [Full Text] [Related]  

  • 51. New synthetic antagonists of bradykinin.
    Schachter M; Uchida Y; Longridge DJ; Labedz T; Whalley ET; Vavrek RJ; Stewart JM
    Br J Pharmacol; 1987 Dec; 92(4):851-5. PubMed ID: 3427282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation by Phoneutria nigriventer (armed spider) venom of tissue kallikrein-kininogen-kinin system in rabbit skin in vivo.
    Marangoni RA; Antunes E; Brain SD; de Nucci G
    Br J Pharmacol; 1993 Jun; 109(2):539-43. PubMed ID: 8395291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Method for determining kallikrein of tissue origin in blood plasma and its clinical significance].
    Surovkina MS; Semenova LV; Semenov VI; Lapshina IM; Volkova TV
    Biull Eksp Biol Med; 1985 Aug; 100(8):249-52. PubMed ID: 3849314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bradykinin derivatives as permeability factors.
    Reis ML; Okino L; Rocha e Silva M
    Agents Actions; 1973 Dec; 3(5):383. PubMed ID: 4785039
    [No Abstract]   [Full Text] [Related]  

  • 55. [Comparative evaluation of the action of nonsteroidal anti-inflammatory preparations on blood plasma kallikrein and the biological effects of bradykinin].
    Shvarts GIa; Paskhina TS; Iakubovskaia RI
    Farmakol Toksikol; 1984; 47(4):74-81. PubMed ID: 6566613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of bradykinin and kallikrein on plasma proteins in the inflammatory process in rabbits].
    Lichota E; Mietkiewski E; Danieyko-Osman M; Legiecka B
    Ann Acad Med Stetin; 1981; 27():343-51. PubMed ID: 6921012
    [No Abstract]   [Full Text] [Related]  

  • 57. Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen.
    Matheson RT; Miller DR; Lacombe MJ; Han YN; Iwanaga S; Kato H; wuepper KD
    J Clin Invest; 1976 Dec; 58(6):1395-406. PubMed ID: 993350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Biological method of determining total kallikrein activity in the plasma of man and laboratory animals].
    Surovikina MS
    Lab Delo; 1975; (1):5-9. PubMed ID: 45974
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies on bradykinin and bradykininogen in malaria.
    Tella A; Maegraith BG
    Ann Trop Med Parasitol; 1966 Sep; 60(3):304-17. PubMed ID: 4961575
    [No Abstract]   [Full Text] [Related]  

  • 60. [Modification of the permeability of the blood capillaries of rabbit skin for macromolecules by some biogenic vascular-active substances].
    FRIMMER M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1961; 242():390-402. PubMed ID: 13895382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.